151 related articles for article (PubMed ID: 22520948)
1. A review of adenoid cystic carcinoma of the breast with emphasis on its molecular and genetic characteristics.
Vranic S; Bender R; Palazzo J; Gatalica Z
Hum Pathol; 2013 Mar; 44(3):301-9. PubMed ID: 22520948
[TBL] [Abstract][Full Text] [Related]
2. IMP3, a proposed novel basal phenotype marker, is commonly overexpressed in adenoid cystic carcinomas but not in apocrine carcinomas of the breast.
Vranic S; Gurjeva O; Frkovic-Grazio S; Palazzo J; Tawfik O; Gatalica Z
Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):413-6. PubMed ID: 21436679
[TBL] [Abstract][Full Text] [Related]
3. ER-α36, a novel isoform of ER-α66, is commonly over-expressed in apocrine and adenoid cystic carcinomas of the breast.
Vranic S; Gatalica Z; Deng H; Frkovic-Grazio S; Lee LM; Gurjeva O; Wang ZY
J Clin Pathol; 2011 Jan; 64(1):54-7. PubMed ID: 21045236
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas.
Kreike B; van Kouwenhove M; Horlings H; Weigelt B; Peterse H; Bartelink H; van de Vijver MJ
Breast Cancer Res; 2007; 9(5):R65. PubMed ID: 17910759
[TBL] [Abstract][Full Text] [Related]
5. Adenoid cystic carcinomas of the breast have low Topo IIα expression but frequently overexpress EGFR protein without EGFR gene amplification.
Vranic S; Frkovic-Grazio S; Lamovec J; Serdarevic F; Gurjeva O; Palazzo J; Bilalovic N; Lee LM; Gatalica Z
Hum Pathol; 2010 Nov; 41(11):1617-23. PubMed ID: 20688355
[TBL] [Abstract][Full Text] [Related]
6. Salivary gland-type lung carcinomas: an EGFR immunohistochemical, molecular genetic, and mutational analysis study.
Macarenco RS; Uphoff TS; Gilmer HF; Jenkins RB; Thibodeau SN; Lewis JE; Molina JR; Yang P; Aubry MC
Mod Pathol; 2008 Sep; 21(9):1168-75. PubMed ID: 18587327
[TBL] [Abstract][Full Text] [Related]
7. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including "triple negative carcinomas" of low malignant potential.
Foschini MP; Krausz T
Semin Diagn Pathol; 2010 Feb; 27(1):77-90. PubMed ID: 20306833
[TBL] [Abstract][Full Text] [Related]
8. Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers.
Wetterskog D; Lopez-Garcia MA; Lambros MB; A'Hern R; Geyer FC; Milanezi F; Cabral MC; Natrajan R; Gauthier A; Shiu KK; Orr N; Shousha S; Gatalica Z; Mackay A; Palacios J; Reis-Filho JS; Weigelt B
J Pathol; 2012 Jan; 226(1):84-96. PubMed ID: 22015727
[TBL] [Abstract][Full Text] [Related]
9. MYB Labeling by Immunohistochemistry Is More Sensitive and Specific for Breast Adenoid Cystic Carcinoma than MYB Labeling by FISH.
Poling JS; Yonescu R; Subhawong AP; Sharma R; Argani P; Ning Y; Cimino-Mathews A
Am J Surg Pathol; 2017 Jul; 41(7):973-979. PubMed ID: 28498281
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactivity for c-kit and p63 as an adjunct in the diagnosis of adenoid cystic carcinoma of the breast.
Mastropasqua MG; Maiorano E; Pruneri G; Orvieto E; Mazzarol G; Vento AR; Viale G
Mod Pathol; 2005 Oct; 18(10):1277-82. PubMed ID: 15846389
[TBL] [Abstract][Full Text] [Related]
11. KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome.
Azoulay S; Laé M; Fréneaux P; Merle S; Al Ghuzlan A; Chnecker C; Rosty C; Klijanienko J; Sigal-Zafrani B; Salmon R; Fourquet A; Sastre-Garau X; Vincent-Salomon A
Mod Pathol; 2005 Dec; 18(12):1623-31. PubMed ID: 16258515
[TBL] [Abstract][Full Text] [Related]
12. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
13. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
Ramezani F; Salami S; Omrani MD; Maleki D
Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
[TBL] [Abstract][Full Text] [Related]
14. Proliferative activity and p53 expression in adenoid cystic carcinoma of the breast.
Pastolero G; Hanna W; Zbieranowski I; Kahn HJ
Mod Pathol; 1996 Mar; 9(3):215-9. PubMed ID: 8685217
[TBL] [Abstract][Full Text] [Related]
15. Locally Advanced Adenoid Cystic Carcinoma of the Breast-A Case Report with a Review of the Literature.
Rypel J; Kubacka P; Mykała-Cieśla J; Pająk J; Bulska-Będkowska W; Chudek J
Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004055
[TBL] [Abstract][Full Text] [Related]
16. Adenoid cystic carcinoma of the breast: a tumour commonly devoid of oestrogen receptors and related proteins.
Trendell-Smith NJ; Peston D; Shousha S
Histopathology; 1999 Sep; 35(3):241-8. PubMed ID: 10469216
[TBL] [Abstract][Full Text] [Related]
17. Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer.
Fusco N; Geyer FC; De Filippo MR; Martelotto LG; Ng CK; Piscuoglio S; Guerini-Rocco E; Schultheis AM; Fuhrmann L; Wang L; Jungbluth AA; Burke KA; Lim RS; Vincent-Salomon A; Bamba M; Moritani S; Badve SS; Ichihara S; Ellis IO; Reis-Filho JS; Weigelt B
Mod Pathol; 2016 Nov; 29(11):1292-1305. PubMed ID: 27491809
[TBL] [Abstract][Full Text] [Related]
18. Resolving quandaries: basaloid adenoid cystic carcinoma or breast cylindroma? The role of massively parallel sequencing.
Fusco N; Colombo PE; Martelotto LG; De Filippo MR; Piscuoglio S; Ng CK; Lim RS; Jacot W; Vincent-Salomon A; Reis-Filho JS; Weigelt B
Histopathology; 2016 Jan; 68(2):262-71. PubMed ID: 25951887
[TBL] [Abstract][Full Text] [Related]
19. MYB rearrangement and immunohistochemical expression in adenomyoepithelioma of the breast: a comparison with adenoid cystic carcinoma.
Baraban E; Zhang PJ; Jaffer S; Lubin D; Feldman M; Bleiweiss IJ; Nayak A
Histopathology; 2018 Dec; 73(6):897-903. PubMed ID: 30003572
[TBL] [Abstract][Full Text] [Related]
20. Triple-negative breast cancer: current state of the art.
Rastelli F; Biancanelli S; Falzetta A; Martignetti A; Casi C; Bascioni R; Giustini L; Crispino S
Tumori; 2010; 96(6):875-88. PubMed ID: 21388048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
